| Zhang, Zhen |
| Active, not recruiting | 4 | 1127 | RoW | Yangzheng Compound Mixture, Z10970042（NMPA Approval Number）, Conventional Treatment | ShuGuang Hospital, LinkDoc Technology (Beijing) Co. Ltd., Shaanxi Buchang Pharmaceutical Co., Ltd | Carcinoma, Sleep Disorder | 09/23 | 06/24 | | |
PREACT, NCT03013010: Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy |
|
|
| Recruiting | 3 | 682 | RoW | Tegafur-Gimeracil-Oteracil Potassium, S-1, Chemoradiotherapy, radiochemotherapy, Gastric resection, Gastrectomy, Oxaliplatin | Shanghai Cancer Hospital, China, Fudan University, Ruijin Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Huadong Hospital | Stomach Neoplasm, GastroEsophageal Cancer, Adenocarcinoma, Locally Advanced Cancer, Chemoradiation | 12/23 | 12/23 | | |
NCT05439629: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration |
|
|
| Active, not recruiting | 3 | 488 | RoW | BAT5906 injection, Lucentis | Bio-Thera Solutions | Neovascular (Wet) Age-related Macular Degeneration | 04/24 | 06/25 | | |
| Not yet recruiting | 3 | 420 | RoW | Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Cancer | 12/27 | 06/29 | | |
NCT04997837: Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma |
|
|
| Recruiting | 3 | 433 | RoW | PD-1 inhibitor, Oxaliplatin, Capecitabine, Tegafur-gimeracil-oteracil potassium, 5-FU, Radiotherapy, Chemotherapy | Fudan University | Gastric Cancer | 07/27 | 10/27 | | |
NCT04499586: A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer |
|
|
| Active, not recruiting | 2 | 30 | RoW | Radiotherapy Combined With Raltitrexed and Irinotecan | Fudan University | Recurrent Colorectal Cancer | 08/20 | 12/20 | | |
NCT04411537: The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer |
|
|
| Not yet recruiting | 2 | 50 | RoW | PD-1 antibody, Capecitabine, Xeloda, Irinotecan, Neoadjuvant Radiotherapy | Fudan University | Locally Advanced Rectal Cancer | 04/22 | 12/22 | | |
NCT04411524: The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer |
|
|
| Not yet recruiting | 2 | 50 | RoW | PD-1 antibody, Capecitabine, Xeloda, Irinotecan, Neoadjuvant Radiotherapy | Fudan University | Locally Advanced Rectal Cancer | 04/22 | 12/22 | | |
NCT04394598: A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 210 | RoW | Dendrobium Huoshanense Granules, Pelvic Radiation, Capecitabine, Irinotecan, Placebo | Fudan University | Locally Advanced Rectal Cancer | 06/22 | 12/22 | | |
NCT04535024: The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer |
|
|
| Recruiting | 2 | 60 | RoW | Stereotactic Ablative Radiotherapy (SABR), Sintilimab | Fudan University | Colorectal Cancer | 06/22 | 12/22 | | |
RIFLE, NCT04948034: The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer |
|
|
| Recruiting | 2 | 68 | RoW | Stereotactic Ablative Radiotherapy (SABR), Fruquintinib, Tislelizumab | Fudan University | Metastatic Colorectal Cancer | 12/22 | 12/23 | | |
NeoRacing, NCT05161572: Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer |
|
|
| Recruiting | 2 | 152 | RoW | Oxaliplatin, Tegafur-Gimeracil-Oteracil, Sintilimab, Concurrent chemoradiation, D2/R0 gastrectomy | Fudan University | Stomach Neoplasms, Esophagogastric Junction Disorder, Neoadjuvant Therapy, Chemoradiotherapy, Immunotherapy, Gastrectomy, Adenocarcinoma, Adjuvant Therapy | 09/23 | 09/26 | | |
TORCH, NCT04518280: Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer |
|
|
| Completed | 2 | 130 | RoW | PD-1 antibody, Toripalimab, Capecitabine, Xeloda, Oxaliplatin, Short-course radiotherapy | Fudan University | Locally Advanced Rectal Cancer | 09/23 | 01/25 | | |
TORCH-iTNT, NCT06281405: CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer |
|
|
| Not yet recruiting | 2 | 198 | RoW | PD-1 antibody, Toripalimab, Capecitabine, Short-course radiotherapy | Fudan University | Locally Advanced Rectal Cancer, Neoadjuvant Therapy | 06/26 | 12/28 | | |
TORCH-E2, NCT06462053: Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer |
|
|
| Recruiting | 2 | 134 | RoW | Short-course radiotherapy, SCRT, PD-1 antibody (Toripalimab), Toripalimab, Long-course radiotherapy, LCRT, Oxaliplatin, Capecitabine, Xeloda | Fudan University | Early Low Rectal Cancer | 04/26 | 03/27 | | |
SLOT, NCT05963490: Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer |
|
|
| Recruiting | 2 | 108 | RoW | Regorafenib, Stivarga, Toripalimab, Radiotherapy | Fudan University | Microsatellite Stable Metastatic Colorectal Cancer | 04/25 | 04/26 | | |
TORCH-LE, NCT06455124: Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer |
|
|
| Recruiting | 2 | 60 | RoW | Radiation, PD-1 antibody, Toripalimab, Capecitabine, Xeloda, Oxaliplatin | Fudan University | Rectal Cancer | 06/26 | 12/29 | | |
TORCH-G, NCT06728657: Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma |
|
|
| Recruiting | 2 | 68 | RoW | HFRT targeted to the primary lesion and positive lymph nodes, PULSAR targeted to the primary lesion and positive lymph nodes, Anti-PD-1 monoclonal antibody, Chemotherapy, R0 total/subtotal gastrectomy with D2 lymphadenectomy | Fudan University | Stomach Adenocarcinoma, Gastro-esophageal Junction Cancer | 12/25 | 12/28 | | |
TORCH-E, NCT05555888: The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer |
|
|
| Recruiting | 2 | 34 | RoW | PD-1 antibody, Toripalimab, Capecitabine, Xeloda, Oxaliplatin, Short-course radiotherapy | Fudan University | Early Low Rectal Cancer | 03/24 | 05/25 | | |
TORCH-R, NCT05628038: The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer |
|
|
| Recruiting | 2 | 93 | RoW | PD-1 antibody, Toripalimab, Capecitabine, Xeloda, 5FU, folinic acid, Oxaliplatin, Irinotecan, Raltitrexed, Cetuximab, Bevacizumab, Radiation | Fudan University | Recurrent Rectal Cancer | 12/24 | 12/25 | | |
Miracle-G, NCT06121700: Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer |
|
|
| Recruiting | 2 | 55 | RoW | Radiotherapy targeted to the primary lesion, Radiotherapy targeted to the metastatic lesions, Anti-PD-1 monoclonal antibody, Trastuzumab, Herceptin®, Chemotherapy, R0 total/subtotal gastrectomy with D2 lymphadenectomy, Metastasectomy, Local ablative therapies | Fudan University | Adenocarcinoma, Stomach Neoplasm, Gastroesophageal-junction Cancer, Oligometastatic Disease, Metastatic Cancer, Metastatic Gastric Cancer, Adenocarcinoma of the Stomach, Gastroesophageal Junction Adenocarcinoma, Metastatic Adenocarcinoma | 12/25 | 12/27 | | |
IRIS, NCT05839275: The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma |
|
|
| Recruiting | 1/2 | 52 | RoW | Surufatinib, Sintilimab, Radiotherapy | Fudan University | High-Risk Localized Soft Tissue Sarcoma | 07/24 | 07/29 | | |
RAPID, NCT05774275: The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma |
|
|
| Recruiting | 1/2 | 52 | RoW | Pegylated Liposomal Doxorubicin, Doxil, Doxorubicin, Doxorubicin Hydrochloride, Anti-PD-1 monoclonal antibody, Sintilimab, Radiotherapy | Fudan University | High-Risk Localized Soft Tissue Sarcoma | 08/24 | 08/29 | | |
NCT04886778: Efficacy and Safety of Low-Carbohydrate Diet Combined With Probiotics for Weight Loss in Male Obese Patients. |
|
|
| Completed | N/A | 44 | RoW | Low-carbohydrate diet, Probiotic compound preparations, Junyi Yili® Probiotics, Placebo | Sun Jia | Obesity | 03/22 | 03/22 | | |
NCT05688033: Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During Chemoradiotherapy |
|
|
| Active, not recruiting | N/A | 200 | RoW | dosimetric limitation of pelvic bone and peritoneal space during radiotherapy | Fudan University | Rectal Cancer | 08/22 | 12/23 | | |
| Not yet recruiting | N/A | 1500 | RoW | adrenal venous sampling | Chinese Academy of Medical Sciences, Fuwai Hospital | Hyperaldosteronism | 12/26 | 12/26 | | |
NCT06016777: Optimization of Perioperative Analgesia Protocol for Uniportal Video-assisted Thoracoscopic Surgery |
|
|
| Recruiting | N/A | 102 | RoW | Ultrasound-guided paraspinal block and patient-controlled intravenous analgesia pump, Ultrasound-guided erector spinal block and patient-controlled intravenous analgesia pump, Patient-controlled intravenous analgesia pump | China-Japan Friendship Hospital | Uniportal Video-assisted Thoracic Surgery | 09/25 | 10/25 | | |
| Recruiting | N/A | 2500 | RoW | Intrathrombus Thrombolysis During Primary PCI, Aspiration Thrombectomy During Primary PCI | China-Japan Friendship Hospital | Acute Coronary Syndrome, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention | 03/26 | 09/26 | | |
| Sun, Wenjie |
| No trials found |
